Celldex Therapeutics, Inc. — Director's Dealing 2016

Sep 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2016-09-02

Reporting Person: KELER TIBOR (Executive VP & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-02	Common Stock, par value $0.001 per share	P	3000	$3.32	Acquired	18868	Direct